NYSE:EBS
Emergent Biosolutions, Inc.
- Stock
locale
United States
market
STOCKSindustry
Drug Manufacturers - Specialty & Genericwebsite
www.emergentbiosolutions.comipo date
Nov 15, 2006
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus